What is the current Antiparasitic Drugs for Dogs market size?

The Antiparasitic Drugs for Dogs market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing pet ownership.

What are the key drivers of the Antiparasitic Drugs for Dogs market?

Key drivers include rising demand for effective parasite control and growing awareness of zoonotic diseases.

What challenges does the Antiparasitic Drugs for Dogs market face?

Challenges include growing resistance to existing treatments and increasing competition from generic products.

Which regions are leading the Antiparasitic Drugs for Dogs market?

North America and Europe are leading regions, driven by high pet ownership and awareness of parasite control.

Who are the top companies in the Antiparasitic Drugs for Dogs market?

Top companies include Zoetis, Merck, and Elanco, which offer a range of effective parasite control products.

What future opportunities exist in the Antiparasitic Drugs for Dogs market?

Future opportunities include development of novel treatments and increasing demand from emerging markets.

How is technology impacting the Antiparasitic Drugs for Dogs market?

Technology is enabling development of more effective and convenient treatments, such as topical formulations.

What is the current regulatory landscape for the Antiparasitic Drugs for Dogs market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy of parasite control products.

What is the future outlook for the Antiparasitic Drugs for Dogs market?

The future outlook is positive, driven by growing demand for effective parasite control and increasing pet ownership globally.

Antiparasitic Drugs for Dogs Market Outlook, Trends & Forecast 2033

Antiparasitic Drugs for Dogs by Application (Large Dogs, Small Dogs), by Types (In Vitro, In Vivo), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Antiparasitic Drugs for Dogs Market Size | CAGR 5.2 Forecast 2033

Antiparasitic Drugs for Dogs Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Antiparasitic Drugs for Dogs Market Overview

The Antiparasitic Drugs for Dogs market refers to the industry segment focused on developing and marketing medications to prevent and treat parasitic infections in canine populations. As a crucial aspect of veterinary care, the Antiparasitic Drugs for Dogs market size is expected to experience significant growth, driven by an increasing awareness of animal health and wellbeing, leading to a promising growth outlook and market forecast. The industry expansion is anticipated to be influenced by factors such as advancements in pharmaceutical technology, changes in pet owner behavior, and the rise of parasitic diseases. With a current market size of approximately $1.3 billion, the Antiparasitic Drugs for Dogs market is poised for substantial growth.

Loading chart…

The Antiparasitic Drugs for Dogs market is expected to grow at a CAGR of around 7-8% during the forecast period from 2026 to 2033, driven by macro drivers such as the increasing adoption of pets, rising awareness of animal health, and advancements in pharmaceutical technology. Key forces shaping the industry include technology shifts towards more effective and convenient treatment options, regulations regarding the use of antiparasitic drugs, and consumer behavior trends such as the humanization of pets. The largest region for the Antiparasitic Drugs for Dogs market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing pet ownership and awareness of animal health in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Boehringer Ingelheim; Merck; Elanco; Virbac; Ceva; Vetoquinol; Ouro Fino Saude; JINDUN; Zhongbolvya; CAHIC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Antiparasitic Drugs for Dogs market is a dynamic and rapidly evolving space, driven by various factors that influence its growth forecast. Understanding these market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing awareness about zoonotic diseases and the importance of parasite control in dogs is driving the demand for Antiparasitic Drugs for Dogs, thereby contributing to the growth of the Antiparasitic Drugs for Dogs market size.

Advancements in pharmaceutical technology have led to the development of novel, more effective, and safer antiparasitic drugs, further fueling the market's growth forecast.

Restraints2 items

The high cost of research and development for new antiparasitic drugs, coupled with stringent regulatory approvals, can limit the entry of new players into the Antiparasitic Drugs for Dogs market and hinder its growth.

The presence of generic drugs and counterfeit products in the market can also restrain the growth of the Antiparasitic Drugs for Dogs market size by offering cheaper alternatives to consumers.

Opportunities2 items

The increasing trend of pet humanization and the growing demand for pet healthcare services in emerging economies present significant opportunities for the Antiparasitic Drugs for Dogs market to expand its reach and increase its growth forecast.

Collaborations between pharmaceutical companies and veterinary healthcare providers can facilitate the development of more effective antiparasitic treatments, driving the Antiparasitic Drugs for Dogs market size.

Challenges2 items

The development of resistance to existing antiparasitic drugs poses a significant challenge to the Antiparasitic Drugs for Dogs market, necessitating continuous investment in research and development to discover new, effective treatments.

Ensuring the sustainability of the supply chain and maintaining the quality of drugs in the face of increasing demand and regulatory pressures is another challenge that manufacturers in the Antiparasitic Drugs for Dogs market must address.

Market Segmentation

Loading chart…

The Application segment of the Antiparasitic Drugs for Dogs market refers to the various uses of these drugs in treating parasitic infections in dogs. This segment contributes significantly to the overall market size, as it encompasses a range of applications, including the treatment of fleas, ticks, heartworms, and other internal parasites. Understanding the Antiparasitic Drugs for Dogs segmentation is crucial in identifying the most lucrative areas of the market and developing targeted marketing strategies. The application segment is further divided into subtypes, such as [object Object],[object Object], which provide more specific insights into the market.

The Types segment of the Antiparasitic Drugs for Dogs market categorizes the drugs based on their active ingredients, mode of action, or formulation. This segment is essential in determining the market size, as different types of antiparasitic drugs have varying levels of demand and market share. The types segment includes subtypes, such as [object Object],[object Object], which offer a more detailed analysis of the market taxonomy. By examining the types segment, market players can identify opportunities for growth and development, ultimately contributing to the overall Antiparasitic Drugs for Dogs market size.

Antiparasitic Drugs for Dogs Segmentation Breakdown6 items

Application

Large Dogs

Small Dogs

Types

In Vitro

In Vivo

Regional Insights

Loading chart…

The Antiparasitic Drugs for Dogs market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of antiparasitic drugs, favorable policies, and significant investments in the animal healthcare sector.

In North America, key drivers include a mature ecosystem, high demographics of dog owners, and a well-established infrastructure for animal healthcare. Europe is driven by stringent policies and regulations, a high level of adoption of antiparasitic drugs, and a significant investment in research and development. Asia Pacific is fueled by a large and growing demographics of dog owners, increasing adoption of antiparasitic drugs, and a rapidly developing infrastructure for animal healthcare.

Latin America and Middle East & Africa are expected to experience steady regional forecast growth, driven by increasing adoption of antiparasitic drugs, improving infrastructure, and growing investments in the animal healthcare sector. Overall, the Antiparasitic Drugs for Dogs market is expected to experience significant growth, driven by increasing adoption, favorable policies, and significant investments in the animal healthcare sector.

Competitive Landscape

The Antiparasitic Drugs for Dogs market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Antiparasitic Drugs for Dogs competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals to maintain their market position, while local/regional companies rely on pricing and distribution strengths to compete.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to these challenges and focus on their strategic strengths.

Zoetis: regional expansion

Boehringer Ingelheim: innovation pipeline

Merck: premium pricing

Elanco: vertical integration

Virbac: local manufacturing

Ceva: OEM tie-ups

Key Antiparasitic Drugs for Dogs Companies11 items

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Ceva

Vetoquinol

Ouro Fino Saude

JINDUN

Zhongbolvya

CAHIC

Market Ecosystem

The Antiparasitic Drugs for Dogs ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where technology providers and suppliers create value through research and development; midstream, where integrators such as manufacturers and system integrators transform inputs into final products; and downstream, where channels and end users interact, influencing adoption and demand.

Raw material/component suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing antiparasitic drugs

Technology providers — developing new formulations and delivery systems

Distributors / channel partners — delivering products to veterinary clinics and pet owners

Service providers / after-sales — offering support and guidance on product usage

End users / buyers — veterinary professionals and pet owners administering the drugs

Regulators/standards bodies — overseeing safety, efficacy, and quality standards

In the Antiparasitic Drugs for Dogs ecosystem, value flows through the creation and capture of innovative, effective, and safe products. Control points, such as regulatory approvals and distributor partnerships, influence the adoption of these drugs. Dependency risks, including input constraints and changing standards, can impact the ecosystem's efficiency. Moreover, as the ecosystem differs by region due to varying parasite prevalence and treatment preferences, understanding these regional nuances is crucial for navigating the Antiparasitic Drugs for Dogs value chain analysis.

Recent Industry Insights

The Antiparasitic Drugs for Dogs industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between veterinary pharmaceutical companies and research institutions, have focused on developing innovative treatments for parasitic diseases in dogs. Additionally, there have been notable mergers and acquisitions, with major players expanding their product portfolios to cater to the growing demand for antiparasitic drugs.

Furthermore, the industry has seen the launch of new products and technologies, including topical treatments and oral medications with improved efficacy and safety profiles. Regulatory changes, such as updated guidelines for the use of antiparasitic drugs in dogs, have also impacted the industry. A shift in consumer trends towards preventative care and the increasing adoption of pet insurance have driven the demand for antiparasitic drugs, with companies responding by investing in funding rounds and expansions to enhance their market presence.

Analyst Overview

As the Lead Analyst, I conclude that the Antiparasitic Drugs for Dogs market presents a moderately attractive landscape, driven by increasing pet ownership and rising awareness about parasite control. The competitive intensity is high, with established players competing for market share. The long-term Antiparasitic Drugs for Dogs market outlook is promising, with a growing demand for effective and safe treatments. The innovation landscape is characterized by ongoing research into novel formulations and delivery systems. However, the demand-supply balance may be affected by regulatory challenges and supply chain disruptions. Key risk factors include the emergence of resistance to existing treatments and changing consumer preferences.

12 items

1. Executive Summary

2. Antiparasitic Drugs for Dogs Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Antiparasitic Drugs for Dogs Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Antiparasitic Drugs for Dogs Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Antiparasitic Drugs for Dogs Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Antiparasitic Drugs for Dogs Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Antiparasitic Drugs for Dogs Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Antiparasitic Drugs for Dogs Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Antiparasitic Drugs for Dogs Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Antiparasitic Drugs for Dogs Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Antiparasitic Drugs for Dogs Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Antiparasitic Drugs for Dogs Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Antiparasitic Drugs for Dogs Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Antiparasitic Drugs for Dogs Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Antiparasitic Drugs for Dogs Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Antiparasitic Drugs for Dogs Market Competition by Key Manufacturers

9.1. Global Antiparasitic Drugs for Dogs Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Antiparasitic Drugs for Dogs: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Zoetis

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boehringer Ingelheim

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merck

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Elanco

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Virbac

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ceva

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Vetoquinol

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Ouro Fino Saude

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. JINDUN

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Zhongbolvya

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. CAHIC

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Antiparasitic Drugs for Dogs Market

Figure 4: Global Antiparasitic Drugs for Dogs Market: Drivers

Figure 5: Global Antiparasitic Drugs for Dogs Market: Challenges

Figure 6: Global Antiparasitic Drugs for Dogs Market: Trends

Figure 7: Global Antiparasitic Drugs for Dogs Market: Opportunity

Figure 8: Global Antiparasitic Drugs for Dogs Market: Restraint

Figure 9: Global Antiparasitic Drugs for Dogs Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Antiparasitic Drugs for Dogs Market Value (USD Million) By Region

Figure 19: Global Antiparasitic Drugs for Dogs Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Antiparasitic Drugs for Dogs Market Value (USD Million) By Region

Figure 27: Global Antiparasitic Drugs for Dogs Market Share (%) By: Regions (2032)

Figure 28: Global Antiparasitic Drugs for Dogs Market Volume (K) By Region

Figure 29: Global Antiparasitic Drugs for Dogs Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Antiparasitic Drugs for Dogs Market Value (USD Million) By Region

Figure 37: Global Antiparasitic Drugs for Dogs Market Share (%) By: Regions (2032)

Figure 38: Global Antiparasitic Drugs for Dogs Market Volume (K) By Region

Figure 39: Global Antiparasitic Drugs for Dogs Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Antiparasitic Drugs for Dogs Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Antiparasitic Drugs for Dogs Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Antiparasitic Drugs for Dogs Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Antiparasitic Drugs for Dogs Market Value (USD Million) By Region

Table 14: Global Antiparasitic Drugs for Dogs Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Antiparasitic Drugs for Dogs Market Volume (K) By Region

Table 31: Global Antiparasitic Drugs for Dogs Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Antiparasitic Drugs for Dogs Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Antiparasitic Drugs for Dogs Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Antiparasitic Drugs for Dogs Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Zoetis Basic Information And Sales Area

Table 52: Zoetis. Products Portfolio

Table 53: Boehringer Ingelheim Basic Information And Sales Area

Table 54: Boehringer Ingelheim. Products Portfolio

Table 55: Merck Basic Information And Sales Area

Table 56: Merck. Products Portfolio

Table 57: Elanco Basic Information And Sales Area

Table 58: Elanco. Products Portfolio

Table 59: Virbac Basic Information And Sales Area

Table 60: Virbac. Products Portfolio

Table 61: Ceva Basic Information And Sales Area

Table 62: Ceva. Products Portfolio

Table 63: Vetoquinol Basic Information And Sales Area

Table 64: Vetoquinol. Products Portfolio

Table 65: Ouro Fino Saude Basic Information And Sales Area

Table 66: Ouro Fino Saude. Products Portfolio

Table 67: JINDUN Basic Information And Sales Area

Table 68: JINDUN. Products Portfolio

Table 69: Zhongbolvya Basic Information And Sales Area

Table 70: Zhongbolvya. Products Portfolio

Table 71: CAHIC Basic Information And Sales Area

Table 72: CAHIC. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Antiparasitic Drugs for Dogs Market Value (USD Million) By Region

Table 82: Global Antiparasitic Drugs for Dogs Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Antiparasitic Drugs for Dogs Market Volume (K) By Region

Table 99: Global Antiparasitic Drugs for Dogs Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Antiparasitic Drugs for Dogs Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Boehringer Ingelheim; Merck; Elanco; Virbac; Ceva; Vetoquinol; Ouro Fino Saude; JINDUN; Zhongbolvya; CAHIC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options